PD-1Ig, PD-L1Ig and PD-L2Ig were generated and characterized.
Significantly improved survival was observed in the treatment group compared with control mice.
PD-L1Ig treatment was most efficacious in delaying the disease process.
Even when PD-L1Ig treatment was stop, the most advanced stage of disease was delayed.